Nasdaq · CIK 0001825024
OPAD Offerpad Solutions Inc.
Insider trading from SEC Form 4. Last filing 10 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at Offerpad Solutions Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 22 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Ryan Ohara director | AGrant or award Class A Common Stock | +6,155 | $0.00 | $0 | 42,584 | 10 d ago |
| Sep 30, 2026 | Kenneth D Degiorgio director | AGrant or award Class A Common Stock | +7,520 | $0.00 | $0 | 53,185 | 10 d ago |
| Sep 3, 2026 | Benjamin Graboske director | AGrant or award Class A Common Stock | +33,820 | $0.00 | $0 | 33,820 | 34 d ago |
| Aug 8, 2025 | Donna M Corley director | AGrant or award Class A Common Stock | +71,429 | $0.00 | $0 | 165,597 | Aug 12, 2025 |
| Aug 8, 2025 | Katherine Curnutte director | AGrant or award Class A Common Stock | +71,429 | $0.00 | $0 | 133,122 | Aug 12, 2025 |
| Aug 8, 2025 | Kenneth D Degiorgio director | AGrant or award Class A Common Stock | +71,429 | $0.00 | $0 | 243,986 | Aug 12, 2025 |
| Jul 30, 2025 | Brian Bair Chief Executive Officer | AGrant or award Class A Common Stock | +1,000,000 | $0.00 | $0 | 1,854,404 | Aug 1, 2025 |
| Jul 30, 2025 | Peter H Knag Chief Financial Officer | AGrant or award Class A Common Stock | +465,000 | $0.00 | $0 | 619,289 | Aug 1, 2025 |
| Jun 30, 2025 | Katherine Curnutte director | AGrant or award Class A Common Stock | +26,098 | $0.00 | $0 | 61,693 | Jul 1, 2025 |
| Jun 30, 2025 | Kenneth D Degiorgio director | AGrant or award Class A Common Stock | +32,967 | $0.00 | $0 | 172,557 | Jul 1, 2025 |
| Jun 12, 2025 | Adam Martinez Chief Legal Officer | FTax withholding Class A Common Stock | -2,345 | $1.02 | $2,392 | 24,217 | Jun 16, 2025 |
| Apr 21, 2025 | Donna M Corley director | AGrant or award Class A Common Stock | +93,168 | $0.00 | $0 | 94,168 | Apr 23, 2025 |
| Mar 31, 2025 | Katherine Curnutte director | AGrant or award Class A Common Stock | +14,307 | $0.00 | $0 | 35,595 | Apr 2, 2025 |
| Mar 31, 2025 | Kenneth D Degiorgio director | AGrant or award Class A Common Stock | +18,072 | $0.00 | $0 | 139,590 | Apr 2, 2025 |
| Mar 31, 2025 | Ryan Ohara director | AGrant or award Class A Common Stock | +16,566 | $0.00 | $0 | 70,316 | Apr 2, 2025 |
| Mar 31, 2025 | Sheryl Palmer director | AGrant or award Class A Common Stock | +15,060 | $0.00 | $0 | 68,818 | Apr 2, 2025 |
| Mar 3, 2025 | Benjamin Adam Aronovitch Chief Legal Officer | FTax withholding Class A Common Stock | -391 | $1.65 | $645 | 66,281 | Mar 4, 2025 |
| Feb 25, 2025 | Benjamin Adam Aronovitch Chief Legal Officer | AGrant or award Class A Common Stock | +22,837 | $0.00 | $0 | 73,818 | Feb 27, 2025 |
| Feb 25, 2025 | Peter H Knag Chief Financial Officer | AGrant or award Class A Common Stock | +13,793 | $0.00 | $0 | 158,793 | Feb 27, 2025 |
| Feb 25, 2025 | Benjamin Adam Aronovitch Chief Legal Officer | FTax withholding Class A Common Stock | -7,146 | $2.12 | $15k | 66,672 | Feb 27, 2025 |
| Feb 25, 2025 | Peter H Knag Chief Financial Officer | FTax withholding Class A Common Stock | -4,504 | $2.12 | $9,548 | 154,289 | Feb 27, 2025 |
| Dec 31, 2024 | Kenneth D Degiorgio director | AGrant or award Class A Common Stock | +8,333 | $0.00 | $0 | 121,518 | Jan 3, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Benjamin Adam AronovitchChief Legal Officer
- Brian BairChief Executive Officer
- Donna M Corleydirector
- Katherine Curnuttedirector
- Kenneth D Degiorgiodirector, ceo, officer
- Benjamin Graboskeofficer, director
- Peter H KnagChief Financial Officer
- Adam MartinezChief Legal Officer
- Ryan Oharadirector
- Sheryl Palmerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.